1. Home
  2. FLGC vs ALZN Comparison

FLGC vs ALZN Comparison

Compare FLGC & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flora Growth Corp.

FLGC

Flora Growth Corp.

HOLD

Current Price

$6.71

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$1.90

Market Cap

8.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLGC
ALZN
Founded
2019
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
8.2M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
FLGC
ALZN
Price
$6.71
$1.90
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
70.0K
46.5K
Earning Date
11-05-2025
12-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$57,609,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.71
N/A
52 Week Low
$6.57
$1.88
52 Week High
$47.00
$11.70

Technical Indicators

Market Signals
Indicator
FLGC
ALZN
Relative Strength Index (RSI) 30.73 32.62
Support Level $7.10 $2.10
Resistance Level $7.55 $2.27
Average True Range (ATR) 1.28 0.11
MACD -0.11 -0.02
Stochastic Oscillator 0.41 13.75

Price Performance

Historical Comparison
FLGC
ALZN

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: